These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2306423)

  • 1. Safety of vancomycin in acute porphyria.
    Hift R; Sohnius U; Meissner PN
    Br J Clin Pharmacol; 1990 Feb; 29(2):273-5. PubMed ID: 2306423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology and diagnosis of acute intermittent porphyria].
    Wichmann T; Freye HA
    Z Gesamte Inn Med; 1977 Jun; 32(12):289-92. PubMed ID: 910533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation.
    Doss M; von Tiepermann R; Schneider J; Schmid H
    Klin Wochenschr; 1979 Oct; 57(20):1123-7. PubMed ID: 513604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.
    Sardh E; Rejkjaer L; Andersson DE; Harper P
    Clin Pharmacokinet; 2007; 46(4):335-49. PubMed ID: 17375984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute intermittent porphyria. Detection of asymptomatic carriers of the genetic defect].
    Grandchamp B; Grelier M; Nordmann Y
    Nouv Presse Med; 1975 Jun; 4(24):1801-2. PubMed ID: 1161481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
    Iwanov ED; Adjarov D; Tsanev R
    Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-I-synthase activity.
    Mustajoki P; Tenhunen R
    Eur J Clin Invest; 1985 Oct; 15(5):281-4. PubMed ID: 3935460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the diagnostic usefulness of determining porphobilinogen deaminase activity in the erythrocytes in patients with acute intermittent porphyria and in carriers of the gene of this type of porphyria].
    Gregor A; Kocyłowski M; Kostrzewska E
    Przegl Lek; 1986; 43(11):703-5. PubMed ID: 3575772
    [No Abstract]   [Full Text] [Related]  

  • 11. A modified spectrophotometric assay for porphobilinogen deaminase: its application in the detection of both carriers and patients with acute intermittent porphyria.
    Vázquez-Prado J; Sánchez-Anzaldo FJ; Ruiz-Argüelles GJ; Marín-López E; Lobato-Mendizábal E
    J Inherit Metab Dis; 1995; 18(1):66-71. PubMed ID: 7623445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphobilinogen deaminase in acute intermittent porphyria: activity and concentration in erythrocytes and lymphocytes.
    Lilius L; Lannfelt L; Wetterberg L; Floderus Y; Henrichson A; Thunell S
    Clin Chim Acta; 1991 Feb; 197(1):77-84. PubMed ID: 2044216
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute intermittent porphyria and abdominal pain.
    Male-Velazquez R; Lehman G; Sherman S; Edmonson J
    Dig Dis Sci; 1999 Sep; 44(9):1758. PubMed ID: 10505710
    [No Abstract]   [Full Text] [Related]  

  • 14. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
    Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR
    JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Normal activity of uroporphyrinogen I synthase during an attack of acute intermittent porphyria].
    Kostrzewska E; Gregor A
    Pol Tyg Lek; 1980 Nov; 35(46):1785-6. PubMed ID: 7243643
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic lupus erythematosus and acute intermittent porphyria: coincidence or association ?
    Rosemarin JI; Nigro EJ; Levere RD; Mascarenhas BR
    Arthritis Rheum; 1982 Sep; 25(9):1134-7. PubMed ID: 7126298
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered 5-aminolevulinic acid metabolism leading to pseudoporphyria in hemodialysed patients.
    Guolo M; Stella AM; Melito V; Parera V; Del C Batlle AM
    Int J Biochem Cell Biol; 1996 Mar; 28(3):311-7. PubMed ID: 8920640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria.
    McColl KE; Wallace AM; Moore MR; Thompson GG; Goldberg A
    Clin Sci (Lond); 1982 Feb; 62(2):183-91. PubMed ID: 7053917
    [No Abstract]   [Full Text] [Related]  

  • 19. [Uroporphyrinogen synthase in erythrocytes in acute intermittent porphyria: new pathobiochemical aspects (author's transl)].
    Doss M; von Tiepermann R
    J Clin Chem Clin Biochem; 1978 Feb; 16(2):111-8. PubMed ID: 624910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte uroporphyrinogen I synthase activity as an indicator of acute porphyria.
    Forman DT
    Ann Clin Lab Sci; 1989; 19(2):128-32. PubMed ID: 2751241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.